141 related articles for article (PubMed ID: 37629505)
1. Genomic Surveillance of SARS-CoV-2 in Malaysia during the Era of Endemic COVID-19.
Lee TY; Lim WF; Ang GY; Yu CY
Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629505
[TBL] [Abstract][Full Text] [Related]
2. Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron.
Yu CY; Wong SY; Liew NWC; Joseph N; Zakaria Z; Nurulfiza I; Soe HJ; Kairon R; Amin-Nordin S; Chee HY
Front Med (Lausanne); 2022; 9():1001022. PubMed ID: 36213636
[TBL] [Abstract][Full Text] [Related]
3. Timeline of SARS-CoV-2 Transmission in Sabah, Malaysia: Tracking the Molecular Evolution.
Balakrishnan KN; Yew CW; Chong ETJ; Daim S; Mohamad NE; Rodrigues K; Lee PC
Pathogens; 2023 Aug; 12(8):. PubMed ID: 37624007
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
5. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
Ma KC; Shirk P; Lambrou AS; Hassell N; Zheng XY; Payne AB; Ali AR; Batra D; Caravas J; Chau R; Cook PW; Howard D; Kovacs NA; Lacek KA; Lee JS; MacCannell DR; Malapati L; Mathew S; Mittal N; Nagilla RR; Parikh R; Paul P; Rambo-Martin BL; Shepard SS; Sheth M; Wentworth DE; Winn A; Hall AJ; Silk BJ; Thornburg N; Kondor R; Scobie HM; Paden CR
MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(24):651-656. PubMed ID: 37319011
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
Xia S; Jiao F; Wang L; Yu X; Lu T; Fu Y; Huang Z; Li X; Huang J; Wang Q; Man Q; Xiong L; Jiang S; Lu L
J Med Virol; 2023 Mar; 95(3):e28641. PubMed ID: 36890632
[TBL] [Abstract][Full Text] [Related]
7. Surveillance and Analysis of SARS-CoV-2 Variant Importation - China, January-June 2022.
Feng Y; Zhao X; Yin Z; Wu C; Chen Z; Nie K; A R; Li L; Niu P; Wang J; Wu Y; Wang S; Wang D; Tan W; Wang H; Ma X; Gao GF; Chen C; Xu W
China CDC Wkly; 2022 Dec; 4(50):1136-1142. PubMed ID: 36751558
[TBL] [Abstract][Full Text] [Related]
8. Genomic Surveillance for SARS-CoV-2 Variants: Dominance of XBB Replacement - China, January-June 2023.
Feng Y; Su Q; Li L; He X; Niu P; Guo X; Zhao X; Tang J; Jia Z; Wang J; Wu C; Xia B; Chen Z; Wu Y; Yang J; Chen S; Chen C; Wang S; Dong X
China CDC Wkly; 2024 Apr; 6(15):324-331. PubMed ID: 38736991
[TBL] [Abstract][Full Text] [Related]
9. Complete Genomic Characterisation and Mutation Patterns of Iraqi SARS-CoV-2 Isolates.
Ahmed JQ; Maulud SQ
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611300
[TBL] [Abstract][Full Text] [Related]
10. The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2.
Fang L; Xu J; Zhao Y; Fan J; Shen J; Liu W; Cao G
Front Microbiol; 2023; 14():1228128. PubMed ID: 37560529
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant.
Karyakarte RP; Das R; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Rajmane MV; Kulkarni PP; Nizarudeen S; Joshi S; Potdar V; Karmodiya K
Cureus; 2023 Feb; 15(2):e35261. PubMed ID: 36968876
[TBL] [Abstract][Full Text] [Related]
12. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
[TBL] [Abstract][Full Text] [Related]
13. Systematic Genomic Surveillance of SARS-CoV-2 at Xiamen International Airport and the Port of Xiamen Reveals the Importance of Incoming Travelers in Lineage Diversity.
You R; Wu R; Wang X; Fu R; Xia N; Chen Y; Yang K; Chen J
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257832
[TBL] [Abstract][Full Text] [Related]
14. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
[TBL] [Abstract][Full Text] [Related]
15. Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern.
Katowa B; Kalonda A; Mubemba B; Matoba J; Shempela DM; Sikalima J; Kabungo B; Changula K; Chitanga S; Kasonde M; Kapona O; Kapata N; Musonda K; Monze M; Tembo J; Bates M; Zumla A; Sutcliffe CG; Kajihara M; Yamagishi J; Takada A; Sawa H; Chilengi R; Mukonka V; Muleya W; Simulundu E
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146671
[TBL] [Abstract][Full Text] [Related]
16. Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023.
Kim IH; No JS; Kim JA; Park AK; Lee H; Kim JM; Lee NJ; Kim CK; Lee CY; Woo S; Lee J; Rhee J; Kim EJ
Virology; 2023 Oct; 587():109869. PubMed ID: 37673001
[TBL] [Abstract][Full Text] [Related]
17. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
[TBL] [Abstract][Full Text] [Related]
18. A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB.
Ding Y; Fan F; Xu X; Zhao G; Zhang X; Zhao H; Wang L; Wang B; Gao XM
Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112691
[TBL] [Abstract][Full Text] [Related]
19. A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over.
Ray SK; Mukherjee S
Infect Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38258765
[TBL] [Abstract][Full Text] [Related]
20. Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India.
Karyakarte RP; Das R; Rajmane MV; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Kulkarni PP; Nizarudeen S; Joshi S; Karmodiya K; Potdar V
Cureus; 2023 Jun; 15(6):e39816. PubMed ID: 37397651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
